Cotinine

Cotinine

SCHEMBL49061

CN1C(=O)CCC1c1cccnc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 1.00
CYP3A4 P08684 1/20 1.00
THRB P10828 1/20 1.00
TSHR P16473 1/20 1.00
THPO P40225 1/20 1.00
MEN1 O00255 1/20 1.00
MAPK1 P28482 1/20 1.00
KMT2A Q03164 1/20 1.00
NPSR1 Q6W5P4 1/20 1.00
CHRNB2 P17787 5/20 0.55
CHRNA4 P43681 5/20 0.55
CHRNA7 P36544 4/20 0.55
ALDH1A1 P00352 3/20 0.55
CHRNB4 P30926 2/20 0.55
CHRNA3 P32297 2/20 0.55
CHRNA2 Q15822 2/20 0.55
LMNA P02545 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
HTR3E A5X5Y0 1/20 0.55
PSIP1 O75475 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cotinine SCHEMBL5574865 1.00 KDM4E (1.00) KDM4ECYP3A4THRBTSHRTHPO
Cotinine SCHEMBL30478620 1.00 KDM4E (1.00) KDM4ECYP3A4THRBTSHRTHPO
Cotinine SCHEMBL29404962 1.00 KDM4E (1.00) KDM4ECYP3A4THRBTSHRTHPO
Cotinine SCHEMBL49060 1.00 KDM4E (1.00) KDM4ECYP3A4THRBTSHRTHPO
Cotinine SCHEMBL9067899 1.00 KDM4E (1.00) KDM4ECYP3A4THRBTSHRTHPO
Cotinine SCHEMBL29450216 1.00 KDM4E (1.00) KDM4ECYP3A4THRBTSHRTHPO
Cotinine SCHEMBL10899074 1.00 KDM4E (1.00) KDM4ECYP3A4THRBTSHRTHPO
Cotinine SCHEMBL1615810 0.98 KDM4E (0.97) KDM4ECYP3A4THRBTSHRTHPO
Cotinine SCHEMBL1615812 0.98 KDM4E (0.97) KDM4ECYP3A4THRBTSHRTHPO
Cotinine SCHEMBL4659033 0.98 KDM4E (0.97) KDM4ECYP3A4THRBTSHRTHPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8247 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117735596-B Preparation method of nano zinc sulfide composite material SHANXI KUNMING TOBACCO CO.,LTD. (CN) 2026-05-26 CN claimed
CN-119165094-B Method for detecting psychotropic narcotics in environmental sludge based on acidic condition pretreatment and application 浙江省化工产品质量检验站有限公司 2026-05-15 CN claimed
CN-122016988-A Simultaneous detection method for nicotine, metabolites, neurotransmitters and lipids in brain tissue sample 国家烟草质量监督检验中心 2026-05-12 CN claimed
EP-4482527-B1 CYTOTOXICITY TARGETING CHIMERAS FOR C-C CHEMOKINE RECEPTOR 2-EXPRESSING CELLS GLAXOSMITHKLINE IP DEV LTD (GB) 2026-04-08 EP claimed
EP-4720665-A1 METHOD OF DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE Molecular You Corporation (CA) 2026-04-08 EP claimed
US-20260086100-A1 Method of Determining Risk for Chronic Stress and Stroke UNIV NORTHWEST (ZA) 2026-03-26 US claimed
EP-4007921-B1 METHOD OF DETERMINING RISK FOR CHRONIC STRESS AND STROKE UNIV NORTHWEST (ZA) 2026-03-25 EP claimed
US-20260053182-A1 USE OF PECTIN OR OTHER ANIONIC POLYMERS IN THE STABILIZATION AND CONTROLLED RELEASE OF NICOTINE IN ORAL SENSORIAL TOBACCO PRODUCTS OR NICOTINE CONTAINING NON-TOBACCO ORAL SENSORIAL PRODUCTS ALTRIA CLIENT SERVICES LLC (US) 2026-02-26 US claimed
EP-4698229-A1 BISPECIFIC CYTOTOXICITY TARGETING CHIMERAS GlaxoSmithKline Intellectual Property Development Limited (GB) 2026-02-25 EP claimed
EP-4698225-A1 CYTOTOXICITY TARGETING CHIMERAS FOR ANTIBODY-DRUG CONJUGATES AND BISPECIFIC ANTIBODIES GlaxoSmithKline Intellectual Property Development Limited (GB) 2026-02-25 EP claimed
WO-1993003367-A1 DIFFERENTIAL BINDING AFFINITIES AND DISSOCIATION ASSAYS BASED THEREON SEREX, INC. (US) 1993-02-18 WO claimed
US-5187169-A Cotidine derivatives; Addison's and Parkinson's disease; 3-(1-alkyl-5-oxoindol-2-yl)pyridines; antidepressants; cholinergic agents R. J. REYNOLDS TOBACCO COMPANY (US) 1993-02-16 US claimed
EP-0516746-A1 ORAL COLLECTION FOR IMMUNOASSAY. EPITOPE INC (US) 1992-12-09 EP claimed
WO-1992018868-A1 CROSSTALK INHIBITORS AND THEIR USES BIOSITE DIAGNOSTICS INCORPORATED (US) 1992-10-29 WO claimed
WO-1992012975-A1 HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR IMMUNOASSAYS FOR COTININE ABBOTT LABORATORIES (US) 1992-08-06 WO claimed
US-5103836-A Absorbing saliva in pad impregnated with hypertonic solution; screening tool for diseases EPITOPE, INC. (US) 1992-04-14 US claimed
WO-1991013355-A2 ORAL COLLECTION FOR IMMUNOASSAY EPITOPE, INC. (US) 1991-09-05 WO claimed
EP-0194158-A2 Anti-nicotine and anti-cotinine antibodies (monoclonal and other), and their uses in nicotine and cotinine assays Baylor College of Medicine (US) 1986-09-10 EP claimed
US-4590278-A COTININE, INSECTICIDES PHILIP MORRIS INCORPORATED (US) 1986-05-20 US claimed
US-4332945-A DERIVATIVES OF COTININE PHILIP MORRIS, INCORPORATED (US) 1982-06-01 US claimed